<DOC>
	<DOCNO>NCT02244944</DOCNO>
	<brief_summary>The purpose research gather information combination Zetia® ( Ezetimibe ) Urso Forte® respect sterol balance effect biomarkers liver function subject nonalcoholic fatty liver disease ( NAFLD ) .</brief_summary>
	<brief_title>Ezetimibe-Ursodiol Combination Therapy Biomarkers Liver Function Sterol Balance Subjects With NAFLD</brief_title>
	<detailed_description>The study conduct prospective open label trial pre- post-treatment measure dependent variable . This trial enroll subject clinical diagnosis nonalcoholic fatty liver disease ( NAFLD ) magnetic resonance imaging ( MRI ) , compute tomography ( CT ) ultrasound , include diagnose nonalcoholic steatohepatitis ( NASH ) . Subjects consent , blood collect MRI conduct first visit . Patients advise proper use study drug give first three month 's supply study drug take home . For remain three month , study drug deliver US mail along return packaging prior three month 's study medication order monitor compliance . Patients call routinely encourage compliance , retention , monitor side effect adverse event . After six month study drug administration , subject return follow-up visit . Blood drawn , MRI obtain post-study questionnaire administer . Duration Patient Enrollment : 6 month Duration Study : 18 month</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>Ursodeoxycholic Acid</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>Steatosis ALT &gt; 1.5 time normal ALT/AST ratio &gt; 1.0 Normal Kidney Function Normal ALT within last 6 month Advanced fibrosis base 1 ) biopsy , available ( Stage 3 4 NAFLD ) , 2 ) imaging , 3 ) lab ( platelet count &lt; 150,000 ) Daily alcohol use 20 g/day woman 30 g/day men Prescription use ursodiol , ezetimibe , vitamin E , fish oil , thiazolidinediones , insulin , sulfonylurea , HMGCoA reductase inhibitor Weight loss great 15 % past 12 month Pregnant breastfeed Body Mass index great 50 Largest body circumference great 160 cm Claustrophobia Allergy ezetimibe ursodiol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>nonalcoholic fatty liver disease</keyword>
	<keyword>NAFLD</keyword>
</DOC>